Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 0.0 | 5.0 |
Min SIP Amount | ₹100 | ₹1000 |
Expense Ratio | 0.83 | 0.13 |
NAV | ₹15.54 | ₹32.63 |
Fund Started | 11 Feb 2022 | 19 Jun 2018 |
Fund Size | ₹318.68 Cr | ₹2165.02 Cr |
Exit Load | - | - |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 31.07% | 42.18% |
3 Year | - | 35.11% |
5 Year | - | 25.73% |
1 Year
3 Year
5 Year
Equity | 99.92% | 0.00% |
Cash | 0.08% | 100.00% |
Equity
Cash
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
---|---|
Divi's Laboratories Ltd. | 1.19% |
Bank Of Baroda | 1.13% |
State Bank of India | 1.13% |
Wipro Ltd. | 1.12% |
Grasim Industries Ltd. | 1.10% |
HDFC Life Insurance Co Ltd. | 1.10% |
Eicher Motors Ltd. | 1.09% |
Tech Mahindra Ltd. | 1.09% |
Sun Pharmaceutical Industries Ltd. | 1.08% |
Indian Railway Finance Corporation Ltd. | 1.08% |
Name | Nirman S. Morakhia | Kayzad Eghlim |
Start Date | 15 Feb 2023 | 03 Dec 2021 |
Name
Start Date
Description | The scheme seeks to generate returns that are commensurate (before fees and expenses) with the performance of the NIFTY 100 Equal Weight Index TRI (Underlying Index), subject to tracking error. | The scheme seeks to generate returns by investing in units of BHARAT 22 ETF. |
Launch Date | 11 Feb 2022 | 19 Jun 2018 |
Description
Launch Date